CTOs on the Move

HandsFree Health

www.handsfreehealth.com

 
WellBe® is a digital health platform that provides voice-activated assistance with health questions, reminders, and entertainment using a smart speaker.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Crothall Services Group

Crothall provides optimal laundry and linen services, both in the laundries that we own as well as those that we manage and operate. It is our depth of management expertise, along with our unyielding commitment to quality and customer service, which has

Radiology Affiliates Imaging, LLC

Radiology Affiliates Imaging, LLC is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Lawrenceville, NJ. To find more information about Radiology Affiliates Imaging, LLC, please visit www.4rai.com

Humana Military Healthcare Services

Humana Military Healthcare Services, Inc. is a wholly-owned subsidiary of Humana Inc., one of the largest and most innovative health insurance companies in the country. Humana Military was founded in 1993 and is headquartered in Louisville, Kentucky

Raleigh Hills Assisted Living

Raleigh Hills Assisted Living is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alnylam

Alnylam is the world`s leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market. We are developing RNAi (RNA interference) as an innovative, entirely new class of medicines to treat rare genetic, cardio metabolic, acute hepatic infectious and central nervous system (CNS) and ocular diseases. Alnylam was founded in 2002 based on a Nobel Prize-winning breakthrough in biology – the discovery of RNAi, and a bold vision that this discovery could be used to silence disease-causing genes upstream of today`s medicines. We are relentless in our pursuit of new treatments because we believe that RNAi therapeutics can be used to treat many diseases for which treatment options do not exist or are inadequate. Overall, we believe that patients shouldn`t have to wait for hope. Alnylam is turning scientific possibility into reality - in 2018, the FDA and European EMA approved of our first product, ONPATTRO (patisiran) which is also the first-ever approved RNAi therapeutic. In 2019, the FDA approved our second product, GIVLAARI (givosiran). Our robust pipeline of investigational medicines includes multiple programs in late-stage and early-stage clinical development. We are a global and diverse company of more than 1,500 people. We pride ourself on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That`s why we`ve been named a Science Magazine Top Employer for two years in a row (`19-`20), a Boston Globe Top Place to Work 5x in a row (`15-`19) and one of Fast Company`s 50 Most Innovative Companies for 2019. We are based in Cambridge, U.S., with offices throughout Europe, Asia and South America.